Home
About
Publications Trends
Recent Publications
Expert Search
Archive
basal cell carcinoma (bcc)
How is Basal Cell Carcinoma Diagnosed?
Diagnosis usually involves a
skin examination
by a dermatologist. If a suspicious lesion is found, a biopsy will be performed to confirm the diagnosis. The tissue sample is examined under a microscope to check for cancerous cells.
Frequently asked queries:
What is Basal Cell Carcinoma?
What Causes Basal Cell Carcinoma?
How is Basal Cell Carcinoma Diagnosed?
Can Basal Cell Carcinoma be Prevented?
How can patients keep surgical sites clean?
What are the Symptoms of Lymphoma Spread?
How is Metabolism Assessed?
What Factors Contribute to Cumulative Risk?
How is Communication Facilitated?
What is the ACS Website?
What Are the Challenges with Crosslinking Agents?
How are Results from Prevention Trials Used?
What Role Do Tumor Microenvironment and Cancer Stem Cells Play?
Are There Risks Associated with Anticholinergic Use in Cancer Patients?
What are Some Common Myths About Cancer?
How Can Healthcare Providers Promote Voluntariness?
How Can Time to Diagnosis be Improved?
What is Lobbying in the Context of Cancer?
What is Overall Survival (OS)?
How are CDKs targeted in cancer therapy?
Follow Us
Facebook
Linkedin
Youtube
Instagram
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Nanotechnology
Non-Hodgkin’s Lymphoma
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
CIAbimatoprost
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
diffuse large B-cell lymphoma
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
Keratinocyte
Lipid-based nanoparticles
liver cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
radiotherapy
refractory lymphoma
relapsed lymphoma
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe